MARC details
000 -LEADER |
fixed length control field |
03636pam a2200409 a 4500 |
001 - CONTROL NUMBER |
control field |
3527288 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20230925054503.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
961120s1997 nyua b 001 0 eng c |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
96049906 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0824798090 (hardcover : alk. paper) |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
BUL |
Transcribing agency |
BUL |
Modifying agency |
BUL |
Language of cataloging |
eng |
Description conventions |
rda |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
QS 532.5 E7 ES6 1997 |
Item number |
E7 ES6 1997 |
245 04 - TITLE STATEMENT |
Title |
The endothelium in clinical practice : |
Remainder of title |
source and target of novel therapies / |
Statement of responsibility, etc. |
edited by Gabor M. Rubanyi, Victor J. Dzau. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
New York : |
Name of publisher, distributor, etc. |
M. Dekker, |
Date of publication, distribution, etc. |
c1997. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xvi, 551 p. : |
Other physical details |
ill. ; |
Dimensions |
24 cm. |
490 1# - SERIES STATEMENT |
Series statement |
Fundamental and clinical cardiology ; |
Volume/sequential designation |
29 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 ## - FORMATTED CONTENTS NOTE |
Formatted contents note |
Content<br/>I. The Endothelium as the Source of Novel Therapies<br/>1. Prostacyclin (Prostaglandin I2) and Atherosclerosis, Karsten Schroer<br/>2. Prostacyclin and Thromboxane: Role in Ischemic Heart Disease, Jawahar L. Mehta and Baichun C. Yang<br/>3. Clinical Use of Prostacyclins, John A. Dormandy and Glyn Belcher<br/>4. Nitric Oxide Synthases: Enzymology and Mechanism-Based Inhibitors, John F. Parkinson and Gary Phillips<br/>5. Endothelin: From Basic to Pathophysiological Research, Katsutoshi Goto<br/>6. Transmigration of Leukocytes, B. Stein, Y. Khew-Goodall, J. Gamble, and M. A. Vadas<br/>7. Transforming Growth Factor-b and Cardiovascular Protection, David J. Grainger and James C. Metcalfe<br/>8. Coagulation Factors, Michael Kalafatis, Jack O. Egan, and Kenneth G. Mann<br/><br/>II. The Endothelium as a Target for Novel Therapies <br/>9. Endothelial Dysfunction and Vascular Disease, Paul M. Vanhoutte, Louis Perrault, and Jean Paul Vilaine<br/>10. Complement and Endothelium: Novel Complement-Inhibitory Therapeutics, Una S. Ryan<br/>11. The Receptor for Advanced Gycation Endproducts: Implications for the, Development of Diabetic Vascular Disease, Osamu Hori, Shi Du Yan, and Ann Marie Schmidt<br/>12. Hypertension, Pierre Moreau and Thomas F. Luscher<br/>13. Arterial Restenosis, Michael A. Reidy and Stephen M. Schwartz<br/>14. Pathobiology and Clinical Consequences of Plaque Rupture, Richard Gallo, Juan J. Badimon, James H. Chesebro, Valentin Fuster, and Lina Badimon<br/>15. Isoprostanes and Antioxidant Therapy in Human Diseases, Emma A. Meagher and Garrett A. FitzGerald<br/>16. Vasculoprotection by Estrogen Contributes to Gender Difference in Cardiovascular Diseases: Potential Mechanism and Role of Endothelium, Katalin Kauser and Gabor M. Rubanyi<br/>17. Lipoprotein(a): Insights from Transgenic Mice, Steven D. Hughes and Edward M. Rubin<br/>18. Gene TherapyGene Therapy with Vascular Endothelial Growth Factor, Jeffrey M. Isner<br/>19. Vascular Disease and the Prospect of Gene Therapy, Heiko E. von der Leyen and Victor J. Dzau<br/> |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Vascular endothelium |
General subdivision |
Pathophysiology. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Vascular endothelium |
General subdivision |
Physiology. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Endothelium. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Endothelins. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Thromboxanes. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Prostacyclin. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Heart Diseases |
General subdivision |
therapy. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Heart Diseases |
General subdivision |
physiopathology. |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Endothelium |
General subdivision |
physiology. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Rubanyi, Gabor M., |
Dates associated with a name |
1947- |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Dzau, Victor J. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Fundamental and clinical cardiology ; |
Volume/sequential designation |
v. 29. |
856 42 - ELECTRONIC LOCATION AND ACCESS |
Materials specified |
Publisher description |
Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/enhancements/fy0647/96049906-d.html">http://www.loc.gov/catdir/enhancements/fy0647/96049906-d.html</a> |
906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
a |
7 |
b |
cbc |
c |
orignew |
d |
1 |
e |
ocip |
f |
19 |
g |
y-gencatlg |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
Dewey Decimal Classification |
Koha item type |
Book Open Access |
Classification part |
QS 532.5 E7 ES6 1997 |
Item part |
1 |
Call number prefix |
QS 532.5 |
Call number suffix |
E7 ES6 1997 |